SPOTLIGHT -
Irvine, CA-In anticipation of the initial public offering (IPO) of its common stock, IntraLase Corp. has filed a registration statement with the Securities and Exchange Commission.
Outlook Therapeutics requests Type A meeting with FDA
EyePod: Transforming the MIGS pipeline into clinical reality
BLOG: MicroPulse TLT for patients who struggle with drops
EyePod: Week in Review - September 17, 2023
Kriya announces exclusive license, collaboration, agreement with Everads to advance gene therapies for diseases in ophthalmology, Including GA
Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform